Factors Predicting Outcome for Advanced Gastroesophageal Cancer in Elderly Patients Receiving Palliative Chemotherapy

Abstract Aims Most patients with advanced gastroesophageal cancer are elderly, but current standard regimens have emerged from trials predominantly involving patients with a median age

Saved in:
Bibliographic Details
Published in:Clinical oncology (Royal College of Radiologists (Great Britain)) 2010-03, Vol.22 (2), p.107-113
Main Authors: Lord, S.R, Hall, P.S, McShane, P, Brown, J, Seymour, M.T
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Chemotherapy
elderly
Esophageal Neoplasms - drug therapy
Esophageal Neoplasms - mortality
Esophageal Neoplasms - pathology
Esophagogastric Junction - drug effects
Esophagogastric Junction - pathology
Female
gastric neoplasms
Hematology, Oncology and Palliative Medicine
Humans
Male
Neoplasm Staging
oesophageal neoplasms
Palliative Care
Radiology
Stomach Neoplasms - drug therapy
Stomach Neoplasms - mortality
Stomach Neoplasms - pathology
Survival Rate
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Aims Most patients with advanced gastroesophageal cancer are elderly, but current standard regimens have emerged from trials predominantly involving patients with a median age
ISSN:0936-6555
1433-2981
DOI:10.1016/j.clon.2009.12.001